$PMCB ~ PharmaCyte Biotech, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
$Pistol Pete$
$PMCB ~ PharmaCyte Biotech, Inc. DD

PharmaCyteBiotech-logo.png

$PMCB PharmaCyte Biotech - Diabetes Treatment Program



$PMCB Enjoy Corporate Video



$PMCB Enjoy Discovery Channel Video



$PMCB Enjoy Another Great Video YouTube TGen Leads the Way in Early Detection of Cancer. Dr. Von Hoff will lead $PMCB into FDA Fast Track Approval



$PMCB Progress Report: Pancreatic Cancer Dream Team from Dr. Von Hoff



$PMCB Watch The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport living cells to treat sickness people

PharmaCyteBiotech-logo.png



$PMCB Meet the New SU2C Pancreatic Dream Team with Dr. Von Hoff



$PMCB Management Team and Advisors Board

DC27230C-F981-4F6F-A788-2EEE0279B5D4_zpsweuy4j4g.jpg

$PMCB Products

CIAB_zpshwzyxf8m.jpg

1669962_747232655308611_7115514570173056735_o_zpscacbcd7f.jpg

$PMCB Process

ScreenShot7481.png

10001143_747232388641971_2545329084307033705_o_zps1a42e41b.jpg

373877_236838396388400_435452522_n_zpsd0ca6965.jpg

$PMCB recent news/filings

## source: finance.yahoo.com

Mon, 04 Jan 2016 15:08:25 GMT ~ PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial

[at noodls] - SILVER SPRING, Md., Jan. 04, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using ...

read full: http://www.noodls.com/view/BCB0A017E6037DB9E0...2BC06DFBB2
*********************************************************

Mon, 04 Jan 2016 13:45:00 GMT ~ PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial

[GlobeNewswire] - SILVER SPRING, Md., Jan. 04, 2016-- PharmaCyte Biotech, Inc., a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation ...

read full: http://finance.yahoo.com/news/pharmacyte-biot...00025.html
*********************************************************

Wed, 30 Dec 2015 16:24:50 GMT ~ PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs

[at noodls] - SILVER SPRING, Md., Dec. 30, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using ...

read full: http://www.noodls.com/view/75957AA68BB8F91D4D...6C66176461
*********************************************************

$PMCB
Daily and Weekly Chart






$PMCB company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PMCB/company-info
Ticker: $PMCB
OTC Market Place: OTCQB
CIK code: 0001157075
Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com
Incorporated In: NV, USA

Business Description: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as \"Cell-in-a-Box\" This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer and its symptoms, and diabetes are being developed. PharmaCyte Biotech's treatment for solid tumor cancers involves encapsulating modified live cells capable of converting the prodrug ifosfamide into its active or \"cancer-killing\" form. These encapsulated live cells are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. Ifosfamide is then given intravenously at one third the normal dose to eliminate adverse side effects. When the ifosfamide comes in contact with the encapsulated live cells through the circulatory system, the activation of the drug takes place at or near the tumor. This \"targeted chemotherapy\" has proven remarkably effective and safe to use in past clinical trials. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of the Cannabis plant. It is examining ways to exploit the benefits of Cell-in-a-Box technology in optimizing the anticancer effectiveness of Cannabis, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. In addition to developing treatments for pancreatic and other cancers, PharmaCyte Biotech is developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte Biotech plans to encapsulate a human cell line which has been genetically engineered to produce, store and secrete insulin on demand at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology.Less >>




$PMCB share structure

## source: otcmarkets.com

Market Value: $53,526,861 a/o Dec 14, 2015
Shares Outstanding: 750,826,823 a/o Dec 10, 2015
Float: 529,206,849 a/o Aug 26, 2014
Authorized Shares: 1,490,000,000 a/o Aug 26, 2014
Par Value: 0.0001

$PMCB extra dd links

Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PMCB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PMCB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PMCB+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/news - http://finance.yahoo.com/q/h?s=PMCB+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PMCB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PMCB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PMCB
DTCC (dtcc.com): http://search2.dtcc.com/?q=PharmaCyte+Biotech...ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&am...ech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results...=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://http://ww...maCyte.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://http://w...aCyte.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://http://ww...maCyte.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/compa...yword/PMCB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/financials?...-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?...rch=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PMCB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PMCB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PMCB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PMCB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PMCB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PMCB+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PMCB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PMCB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PMCB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PMCB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PMCB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PMCB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PMCB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PMCB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/st...icker=PMCB

PharmaCyte Biotech Inc. (PMCB) Stock Research Links

PMCB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 8

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 10

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Solvang Teamsters Triumph in Labor Standoff

Updated Category News Views 2

Solvang Strikers Prevail with New Deal Staring down the barrel of a five-week standoff, the hard-nosed workers of Solvang just proved exactly what grit can get you. The City of Solvang and the steadfast members of Teamsters Local 986 wrapped up their punchy back-and-forth by clinching a contract that ups the ante on wages and job respect. For a bunch who stuck it out on...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 0

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 3

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 5

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 4

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 7

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tenant Improvement: Key to Adapting Lease Spaces

Updated Category News Views 1

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 47

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Gilat Satellite Networks Secures Major Defense SATCOM Deal

Updated Category News Views 114

Gilat Satellite Networks Awarded Major Defense Contract Gilat Satellite Networks Ltd. (NASDAQ: GILT), a leader in satellite networking technology, has announced a significant contract awarded to its defense arm, Gilat Defense. This multimillion-dollar deal comes from Israel's Ministry of Defense for the delivery and integration of crucial satellite communication systems...

Continue Reading
Adam Sutton Elevated to Litigation Partner at Cordell & Cordell

Updated Category News Views 218

Exciting Promotion at Cordell & Cordell Cordell & Cordell, a renowned name in family law, has made waves with the announcement of Adam Sutton's promotion to Litigation Partner. This decision comes as part of the firm’s initiative to strengthen its leadership team as they continue to serve clients with excellence. Adam Sutton: A Commitment to Family Law Adam Sutton, who...

Continue Reading
Innovative Solutions Drive Growth in Air Pollution Control Market

Updated Category News Views 291

Emerging Trends in the Air Pollution Control Systems Market The air pollution control systems market is on an upward trajectory, driven by the increasing enforcement of environmental regulations across various sectors worldwide. As businesses strive to comply with these stringent emission standards, the demand for advanced pollution control technologies is witnessing...

Continue Reading
Innovative Household Solutions from the 138th Canton Fair

Updated Category News Views 268

Innovative Approaches at the Canton Fair GUANGZHOU, China — The Canton Fair has become a beacon for exhibitors eager to respond to global consumer shifts toward sustainability and smart design. This year's Phase 2 of the 138th Canton Fair highlights the commitment of Chinese manufacturers to innovate, presenting solutions that not only meet aesthetic demands but also...

Continue Reading
HII's Ingalls Shipbuilding Marks Key Milestone with DDG 129 Launch

Updated Category News Views 264

HII's Major Achievement with the Launch of USS Jeremiah Denton PASCAGOULA, Mississippi — HII’s (NYSE: HII) Ingalls Shipbuilding division has made significant strides in naval defense by launching the future USS Jeremiah Denton (DDG 129), marking the place for the third Flight III Arleigh Burke-class destroyer at its shipyard. The skilled shipbuilders executed an...

Continue Reading